Extracorporeal Shock Wave Lithotripsy for Gallstones: The Shock of the Eighties

por Darzi, A., Monson, J. R. T.
Publicado 1990

m17-1A-, c17-1A- and cSF25-mediated antibody-dependent cell-mediated cytotoxicity in patients with advanced cancer.

por Pullyblank, A. M., Guillou, P. J., Monson, J. R.
Publicado 1994

Interleukin 1 and tumour necrosis factor alpha may be responsible for the lytic mechanism during anti-tumour antibody-dependent cell-mediated cytotoxicity.

por Pullyblank, A. M., Guillou, P. J., Monson, J. R.
Publicado 1995

Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism

por Moyes, V. J., Monson, J. P., Chew, S. L., Akker, S. A.
Publicado 2010

Reply to Mitterer: Conceptual and empirical issues that arise when using correspondence audits to measure racial discrimination

por Block, Ray, Crabtree, Charles, Holbein, John B., Monson, J. Quin
Publicado 2022

Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer

por Chin, K-F, Greenman, J, Gardiner, E, Kumar, H, Topping, K, Monson, J
Publicado 2000

Thyroid dysfunction can predict response to immunotherapy with interleukin-2 and interferon-2 alpha.

por Reid, I., Sharpe, I., McDevitt, J., Maxwell, W., Emmons, R., Tanner, W. A., Monson, J. R.
Publicado 1991

Vascular endothelial growth factor in premenopausal women--indicator of the best time for breast cancer surgery?

por Heer, K., Kumar, H., Speirs, V., Greenman, J., Drew, P. J., Fox, J. N., Carleton, P. J., Monson, J. R., Kerin, M. J.
Publicado 1998

Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer

por Maxwell-Armstrong, C A, Durrant, L G, Buckley, T J D, Scholefield, J H, Robins, R A, Fielding, K, Monson, J R T, Guillou, P, Calvert, H, Carmichael, J, Hardcastle, J D
Publicado 2001